GB2363377B - Novel thieno[2,3-d]pyrimidinediones and therapeutic uses thereof - Google Patents
Novel thieno[2,3-d]pyrimidinediones and therapeutic uses thereofInfo
- Publication number
- GB2363377B GB2363377B GB0014375A GB0014375A GB2363377B GB 2363377 B GB2363377 B GB 2363377B GB 0014375 A GB0014375 A GB 0014375A GB 0014375 A GB0014375 A GB 0014375A GB 2363377 B GB2363377 B GB 2363377B
- Authority
- GB
- United Kingdom
- Prior art keywords
- pyrimidinediones
- therapeutic uses
- novel thieno
- thieno
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0014375A GB2363377B (en) | 2000-06-14 | 2000-06-14 | Novel thieno[2,3-d]pyrimidinediones and therapeutic uses thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0014375A GB2363377B (en) | 2000-06-14 | 2000-06-14 | Novel thieno[2,3-d]pyrimidinediones and therapeutic uses thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
GB0014375D0 GB0014375D0 (en) | 2000-08-02 |
GB2363377A GB2363377A (en) | 2001-12-19 |
GB2363377B true GB2363377B (en) | 2004-06-09 |
Family
ID=9893514
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0014375A Expired - Fee Related GB2363377B (en) | 2000-06-14 | 2000-06-14 | Novel thieno[2,3-d]pyrimidinediones and therapeutic uses thereof |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2363377B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109963858A (en) * | 2016-09-23 | 2019-07-02 | 拜耳股份公司 | N3The thieno uracil and application thereof that ring-type replaces |
CN113816970A (en) * | 2021-09-18 | 2021-12-21 | 济宁医学院附属医院 | Selective copper ion chelating agent, preparation method thereof and application thereof in pulmonary fibrosis |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6890923B2 (en) * | 2002-12-16 | 2005-05-10 | Astrazeneca Ab | Compounds |
JP6725519B2 (en) | 2015-01-22 | 2020-07-22 | ザ スクリプス リサーチ インスティテュート | Heterocyclic monocarboxylic acid transporter inhibitors |
UY36586A (en) | 2015-03-26 | 2016-10-31 | Bayer Pharma AG | HETEROCICLILMETILTIENOURACILOS AND USE OF THE SAME |
WO2018041771A1 (en) | 2016-09-02 | 2018-03-08 | Bayer Pharma Aktiengesellschaft | (1-methylcyclopropyl)methyl-substituted thienouraciles and use thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998054190A1 (en) * | 1997-05-28 | 1998-12-03 | Astra Pharmaceuticals Ltd. | Novel compounds |
WO2000012514A1 (en) * | 1998-08-28 | 2000-03-09 | Astrazeneca Ab | Novel compounds |
-
2000
- 2000-06-14 GB GB0014375A patent/GB2363377B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998054190A1 (en) * | 1997-05-28 | 1998-12-03 | Astra Pharmaceuticals Ltd. | Novel compounds |
WO2000012514A1 (en) * | 1998-08-28 | 2000-03-09 | Astrazeneca Ab | Novel compounds |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109963858A (en) * | 2016-09-23 | 2019-07-02 | 拜耳股份公司 | N3The thieno uracil and application thereof that ring-type replaces |
CN113816970A (en) * | 2021-09-18 | 2021-12-21 | 济宁医学院附属医院 | Selective copper ion chelating agent, preparation method thereof and application thereof in pulmonary fibrosis |
CN113816970B (en) * | 2021-09-18 | 2022-08-09 | 济宁医学院附属医院 | Selective copper ion chelating agent, preparation method thereof and application thereof in pulmonary fibrosis |
Also Published As
Publication number | Publication date |
---|---|
GB2363377A (en) | 2001-12-19 |
GB0014375D0 (en) | 2000-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL159832A0 (en) | 4-amino-6-phenyl-pyrrolo[2,3-d] pyrimidine derivatives | |
AP2002002456A0 (en) | Pyrazolo '4,3-d pyrimidine derivatives | |
GB0004544D0 (en) | Polymers their preparation and uses | |
HUP0200550A2 (en) | Thienopyrimidine compounds, their production and use | |
EP1296699A4 (en) | Therapeutic agents - iii | |
PL358551A1 (en) | 5-aminoalkyl-pyrazolo[4,3-d]pyrimidines | |
IL135982A0 (en) | Fungicidal combinations comprising thieno[2,3-d]pyrimidin-4-one | |
GB2366254B (en) | Child-vehicle pusher's raincover | |
IL160084A0 (en) | Thieno [2,3-d] pyrimidines with combined la and fsh agonistic activity | |
AU2002213429A1 (en) | Antiviral methods and compounds | |
IL142630A0 (en) | FUNGICIDAL COMBINATIONS COMPRISING THIENO [2,3-d] PYRIMIDIN-4-ONE | |
GB2363377B (en) | Novel thieno[2,3-d]pyrimidinediones and therapeutic uses thereof | |
ZA987114B (en) | 3-substituted 3,4,5,7-tetrahydropyrrolol[3',4':4,5] thieno[2,3-D]pyrimidine derivatives, their preparation and use. | |
PL363077A1 (en) | Use of pyrazolo[4,3-d]pyrimidines | |
PL356668A1 (en) | Novel substituted pyrazolo[4,3-e | |
IL151082A0 (en) | Thienopyridine derivatives, their production and use | |
PL361890A1 (en) | Use of pyrazolo[4,3-d]pyrimidines | |
PL365342A1 (en) | Mikanolide derivatives, their preparation and therapeutic uses | |
AU2001285785A1 (en) | 2-aminoalkyl-thieno[2,3-d]pyrimidines | |
AU8578501A (en) | 2-aminoalkyl-thieno(2,3-d)pyrimidines | |
PL371201A1 (en) | 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use | |
AU2001273148A1 (en) | 57658, a human uridine kinase and uses thereof | |
AU2001271244A1 (en) | Novel human uridine kinase | |
AU2001285370A1 (en) | 50566, human glyoxalase ii related factor and uses thereof | |
GB0022753D0 (en) | Polymers their preparation and uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20120614 |